Meiji Yasuda Life Insurance’s Edwards Lifesciences EW Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.43M	Buy	17,900 +10,500	+142%	+$866K	0.05%	112
2025 Q4	$631K	Buy	+7,400	New	+$607K	0.02%	171
2025 Q1	–	Sell	-8,866	Closed	-$656K	–	241
2024 Q4	$656K	Hold	8,866	–	–	0.01%	187
2024 Q3	$585K	Sell	8,866 -6,800	-43%	-$494K	0.01%	183
2024 Q2	$1.45M	Hold	15,666	–	–	0.03%	129
2024 Q1	$1.5M	Buy	15,666 +5,000	+47%	+$420K	0.03%	133
2023 Q4	$813K	Sell	10,666 -10,106	-49%	-$703K	0.02%	184
2023 Q3	$1.44M	Buy	20,772 +1,320	+7%	+$106K	0.04%	125
2023 Q2	$1.83M	Buy	19,452 +8,045	+71%	+$699K	0.05%	98
2023 Q1	$944K	Buy	11,407 +353	+3%	+$27.7K	0.02%	164
2022 Q4	$825K	Sell	11,054 -880	-7%	-$67.8K	0.02%	172
2022 Q3	$986K	Buy	11,934 +738	+7%	+$71K	0.02%	142
2022 Q2	$1.06M	Buy	11,196 +3,177	+40%	+$329K	0.02%	134
2022 Q1	$944K	Sell	8,019 -114	-1%	-$12.8K	0.02%	155
2021 Q4	$1.05M	Buy	8,133 +2,361	+41%	+$275K	0.02%	148
2021 Q3	$653K	Hold	5,772	–	–	0.01%	187
2021 Q2	$598K	Hold	5,772	–	–	0.01%	202
2021 Q1	$483K	Hold	5,772	–	–	0.01%	225
2020 Q4	$527K	Sell	5,772 -3,289	-36%	-$273K	0.01%	200
2020 Q3	$723K	Buy	9,061 +100	+1%	+$7.8K	0.01%	166
2020 Q2	$619K	Hold	8,961	–	–	0.02%	175
2020 Q1	$563K	Sell	8,961 -1,551	-15%	-$112K	0.11%	159
2019 Q4	$817K	Buy	10,512 +1,200	+13%	+$93.7K	0.11%	172
2019 Q3	$683K	Sell	9,312 -450	-5%	-$31.6K	0.1%	181
2019 Q2	$601K	Sell	9,762 -9,771	-50%	-$591K	0.09%	198
2019 Q1	$1.25M	Sell	19,533 -2,385	-11%	-$136K	0.19%	132
2018 Q4	$1.12M	Hold	21,918	–	–	0.17%	147
2018 Q3	$1.27M	Hold	21,918	–	–	0.16%	155
2018 Q2	$1.06M	Sell	21,918 -10,800	-33%	-$504K	0.15%	168
2018 Q1	$1.52M	Hold	32,718	–	–	0.23%	117
2017 Q4	$1.23M	Sell	32,718 -1,782	-5%	-$65.4K	0.17%	153
2017 Q3	$1.26M	Sell	34,500 -8,100	-19%	-$309K	0.19%	143
2017 Q2	$1.68M	Buy	42,600 +8,100	+23%	+$296K	0.26%	100
2017 Q1	$1.08M	Buy	+34,500	New	+$1.08M	0.17%	158
2015 Q1	–	Sell	-10,662	Closed	-$226K	–	329
2014 Q4	$226K	Sell	10,662 -18,000	-63%	-$362K	0.03%	367
2014 Q3	$488K	Buy	+28,662	New	+$452K	0.07%	251
2014 Q2	–	Sell	-26,370	Closed	-$326K	–	378
2014 Q1	$326K	Sell	26,370 -42,054	-61%	-$485K	0.06%	282
2013 Q4	$750K	Buy	68,424 +19,800	+41%	+$223K	0.13%	172
2013 Q3	$564K	Sell	48,624 -11,202	-19%	-$131K	0.1%	206
2013 Q2	$670K	Buy	+59,826	New	+$708K	0.12%	179

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Meiji Yasuda Life Insurance's EW Position: Q1 2026 in Review

Meiji Yasuda Life Insurance increased its Edwards Lifesciences (EW) stake by 142% in Q1 2026, buying an estimated $866K and bringing the position to 17,900 shares worth $1.43M. The position accounts for 0.05% of the portfolio, ranked #112.

Meiji Yasuda Life Insurance first reported a position in EW in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.83M in Q2 2023. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Meiji Yasuda Life Insurance held 17,900 shares of Edwards Lifesciences worth $1.43M as of Q1 2026.
Meiji Yasuda Life Insurance bought 10,500 Edwards Lifesciences shares in Q1 2026, an estimated $866K.
Edwards Lifesciences made up 0.05% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #112 holding.
Meiji Yasuda Life Insurance first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 40 quarters since.
Meiji Yasuda Life Insurance's Edwards Lifesciences position peaked at $1.83M in Q2 2023.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.